Clinical Trial Update: Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone [Phase 2]

View source ↗

Summary

A Phase 2 trial is investigating hyperpolarized 13C pyruvate MRI to monitor response to neoadjuvant abiraterone in high-risk prostate cancer; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Ivan de Kouchkovsky, MD | Conditions: High Risk Prostate Carcinoma, Prostate Cancer | Phase 2 | Status: RECRUITING